Three things drug manufacturers and CEs can do to build trust and enable effective collaboration

The post How Covered Entities and Pharma Companies Can Better Collaborate on Drug Discount Programs appeared first on MedCity News.

Despite misconceptions about its use, artificial intelligence (AI), through modalities such as machine learning models, is poised to enable companies to expedite the drug design process. 

The post The Potential for AI in Drug Design appeared first on MedCity News.

The report, Resilience in volatility: Modernizing the supply chain, highlights three areas that Fortune 500 and mid-size companies need to address to implement technology such as machine learning, cloud computing and risk management tools to improve production and delivery.

The post The supply chain crisis is spurring companies to transform production and sourcing strategies to reduce risk appeared first on MedCity News.

The report, Resilience in volatility: Modernizing the supply chain, highlights three areas that Fortune 500 and mid-size companies need to address to implement technology such as machine learning, cloud computing and risk management tools to improve production and delivery.

The post The supply chain crisis is spurring companies to transform production and sourcing strategies to reduce risk appeared first on MedCity News.

Value-based contracts covering the reimbursement of drugs and medical devices are slowly gaining acceptance. A panel at the MedCity News INVEST conference discussed the challenges and opportunities for these contracts, which aim to improve patient outcomes and control the cost of care.

The post Like it or not, value-based contracting is coming for drugs and medical devices appeared first on MedCity News.

A new partnership between Amazon and First Databank will let users ask Alexa for basic information about the most commonly prescribed drugs.

The post New Alexa feature lets users ask about medications appeared first on MedCity News.

Proteus, which makes tiny sensors that can track medication adherence, will no longer develop the technology in behavioral health medications for Otsuka Pharmaceutical. Instead, the startup is shifting its focus to oncology and infectious diseases, where it hopes its tech will have better traction.

The post Will Proteus’ pivot pay off? appeared first on MedCity News.

Through the 340B program, the government is able to negotiate drug pricing for patients seeking care in certain covered entities and the savings from this program should be passed on to consumers.

The post Does HHS have zero negotiating power in drug pricing? appeared first on MedCity News.

The pharmaceutical industry has introduced extraordinary health-care advances but if we don’t get a handle on the perverse incentives operating throughout the system, we may be pricing ourselves and our economy into oblivion.

The post Why does the cost of prescription drugs keep rising? appeared first on MedCity News.

The biotech century has arrived, and it’s consequently now more important than ever for us to highlight our coverage of biopharma.

The post MedCity News launches biopharma-focused newsletter appeared first on MedCity News.

The report, by PitchBook, shows figures consistent with a similar report earlier this month by Silicon Valley Bank, which forecast more M&A deals this year.

The post Biopharma startup financing had strong showing in 2018, report shows appeared first on MedCity News.

The acquisition brings together two of the largest drugmakers in the country, both of which are major players in biopharma, particularly oncology.

The post Bristol-Myers Squibb to acquire Celgene in $74B deal appeared first on MedCity News.

Although blockchain faces regulatory hurdles and skepticism, its potential as a shared, yet secure ledger system to improve the pharmaceutical supply chain integrity and clinical trials is making it attractive for experimentation and investment by drugmakers.

The post Blockchain becomes a ‘source of truth’ for biopharma appeared first on MedCity News.

The company, which is a distributor of pharmaceuticals and a division of AmerisourceBergen, offers two inventory management systems: CubixxMD and PODIS Plus.

The post How Besse Medical is innovating in inventory management appeared first on MedCity News.

The company’s life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.

The post TraceLink raises $93 million in Series D financing round appeared first on MedCity News.

By complementing life science marketing strategies with Facebook Live, companies will be able to connect with and engage more people in a more familiar and direct manner, which will drive digital word-of-mouth.

The post Bring your pharma brand to life with Facebook Live appeared first on MedCity News.

The post Rethinking aid-in-dying medications appeared first on MedCity News.

Calling Aurinia Pharmaceuticals one happy customer of Philadelphia clinical trial analytics provider Prevail InfoWorks is a gross understatement.

The post Everyone everywhere could only dream of a customer like this appeared first on MedCity News.

The renewed interest in compassionate use — which first emerged as a national issue during the AIDS crisis of the 1980s — also has spurred pharmaceutical companies to ramp up “expanded access” programs.

The post As right-to-try laws gain wider adoption, is stronger federal legislation needed? appeared first on MedCity News.

Exondys 51 doesn’t cure Duchenne muscular dystrophy and will only help a minority of patients.

The post FDA greenlights Sarepta Therapeutics’ milestone treatment for Duchenne muscular dystrophy appeared first on MedCity News.

MyTomorrows has had its greatest success in Europe, but is looking forward to bringing its services to the U.S.

The post MyTomorrows is expanding to the U.S. and bringing its recipe for patient access to clinical trial drugs appeared first on MedCity News.

The post This is how the presidential election is shaping the ongoing drug price debate appeared first on MedCity News.

The post Pharmacy disruptor PillPack has raised another $30.1M following expansion appeared first on MedCity News.

In an outcomes-driven environment, focusing on patients is key but value needs to be demonstrated for all stakeholders when adopting new strategies to go beyond the pill.

The post Beyond the pill: 5 ways to create value with patient-centric services appeared first on MedCity News.

We find the most value in niche companies that can perform one particular service better than anyone else.

The post 3 healthcare sectors that are grabbing the eye of private equity investors appeared first on MedCity News.

The post These companies paid the most to docs last year appeared first on MedCity News.

Drug pricing was destined to be a major topic, as manufacturers and payers continue to duke it out.

The post Microbiota, novel antibiotics, and of course drug pricing among #BIO2016 takeaways appeared first on MedCity News.

Also, Color Genomics expands its genetic test portfolio and Apple rolls out first clinical apps developed with CareKit.

The post Morning Read: Sanofi makes $9.3B offer for Medivation, Alere says it rejected Abbott’s request to scrap M&A deal appeared first on MedCity News.

Some examples of how pharma companies are using social media to boost the drug industry’s 1 percent industrial annual growth rate.

The post Pharma companies, McKinsey highlight social media wins, insights appeared first on MedCity News.

The post Morning Read: Report tracks steep drug price increases by pharma companies appeared first on MedCity News.